Arovella Therapeutics LimitedASX: ALA

SUDA Licenses a Novel iNKT Cell Therapy Platform

Jun 18, 2021 at 4:24 AM UTC · Issued by Arovella Therapeutics Limited

Arovella Therapeutics Ltd has released a press release.

View Attachment